Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to a late diagnosis and poor response to available treatments. There is a need to identify complementary treatment strategies that will enhance the efficacy and reduce the toxicity of currently used therapeutic approaches. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Jiyan, Dhillon, Harsharan, Chikara, Shireen, Mamidi, Sujan, Sreedasyam, Avinash, Chittem, Kishore, Orr, Megan, Wilkinson, John C., Reindl, Katie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828188/
https://www.ncbi.nlm.nih.gov/pubmed/29535819
http://dx.doi.org/10.18632/oncotarget.23623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828188/
https://www.ncbi.nlm.nih.gov/pubmed/29535819
http://dx.doi.org/10.18632/oncotarget.23623

Ejemplares similares